NO20031095L - Farmasoytiske sammensetninger - Google Patents

Farmasoytiske sammensetninger

Info

Publication number
NO20031095L
NO20031095L NO20031095A NO20031095A NO20031095L NO 20031095 L NO20031095 L NO 20031095L NO 20031095 A NO20031095 A NO 20031095A NO 20031095 A NO20031095 A NO 20031095A NO 20031095 L NO20031095 L NO 20031095L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
NO20031095A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031095D0 (no
Inventor
Simon David Bateman
Alberto Gimona
Jurij Holinej
Jasper Huels
Sumedha Jayawardene
Argeris Jerry Karabelas
Maha Y Khaled
Anees Abdulguadar Karnachi
Eimear Mairin Nic Lochlainn
Richard Macerata
Victor Sloan
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20031095L publication Critical patent/NO20031095L/no
Publication of NO20031095D0 publication Critical patent/NO20031095D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20031095A 2000-09-11 2003-03-10 Farmasöytiske sammensetninger NO20031095D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23165500P 2000-09-11 2000-09-11
US23226100P 2000-09-14 2000-09-14
PCT/EP2001/010448 WO2002020090A2 (en) 2000-09-11 2001-09-10 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO20031095L true NO20031095L (no) 2003-03-10
NO20031095D0 NO20031095D0 (no) 2003-03-10

Family

ID=26925315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031095A NO20031095D0 (no) 2000-09-11 2003-03-10 Farmasöytiske sammensetninger

Country Status (28)

Country Link
US (2) US20020061932A1 (pt)
EP (1) EP1331972B1 (pt)
JP (2) JP2004527458A (pt)
KR (1) KR20030036730A (pt)
CN (1) CN100490797C (pt)
AR (1) AR030630A1 (pt)
AT (1) ATE366128T1 (pt)
AU (2) AU2002213900C1 (pt)
BR (1) BR0113809A (pt)
CA (1) CA2416771C (pt)
CY (1) CY1107729T1 (pt)
CZ (1) CZ2003673A3 (pt)
DE (1) DE60129238T2 (pt)
DK (1) DK1331972T3 (pt)
ES (1) ES2290181T3 (pt)
HU (1) HUP0301128A3 (pt)
IL (2) IL154238A0 (pt)
MX (1) MXPA03002105A (pt)
MY (1) MY126117A (pt)
NO (1) NO20031095D0 (pt)
NZ (1) NZ524785A (pt)
PE (1) PE20020351A1 (pt)
PL (1) PL359721A1 (pt)
PT (1) PT1331972E (pt)
RU (1) RU2316324C2 (pt)
SI (1) SI1331972T1 (pt)
SK (1) SK2902003A3 (pt)
WO (1) WO2002020090A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114527A1 (en) * 2001-08-31 2003-06-19 Karnachi Anees Abdulquadar Pharmaceutical composition
GB0201520D0 (en) * 2002-01-23 2002-03-13 Novartis Ag Pharmaceutical uses
PL370907A1 (en) * 2002-03-07 2005-05-30 Novartis Ag Pharmaceutical compositions
JP2006501161A (ja) 2002-06-11 2006-01-12 ニトロメッド インク． ニトロソ化および／またはニトロシル化シクロオキシゲナーゼ−２選択的阻害剤、組成物ならびに使用方法
PE20040844A1 (es) 2002-11-26 2004-12-30 Novartis Ag Acidos fenilaceticos y derivados como inhibidores de la cox-2
TWI327913B (en) * 2003-03-12 2010-08-01 Novartis Ag Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
US20050131028A1 (en) * 2003-09-11 2005-06-16 Pharmacia Corporation Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders
FR2898492B1 (fr) * 2006-03-15 2008-06-06 Pierre Fabre Medicament Sa Comprimes orodispersibles de domperidone
WO2008008120A1 (en) * 2006-07-14 2008-01-17 Fmc Corporation Solid form
WO2008086537A2 (en) * 2007-01-11 2008-07-17 Analog Devices, Inc. Aluminum based bonding of semiconductor wafers
US20110144206A1 (en) * 2008-08-22 2011-06-16 Steven Lewitzky Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity
WO2010056741A2 (en) 2008-11-12 2010-05-20 Auspex Pharmaceuticals, Inc. Phenylacetic acid inhibitors of cyclooxygenase
CN103773596B (zh) * 2013-12-31 2016-05-18 上海复力生物医药科技有限公司 磷虾油的制备方法
CN111278433A (zh) 2017-09-26 2020-06-12 特沙诺有限公司 尼拉帕尼制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2163111C (en) * 1993-06-08 2010-10-26 Peter Heinrich Stahl Process for the preparation of an oral solid dosage form containing diclofenac
JPH11512754A (ja) * 1996-05-17 1999-11-02 メルク エンド カンパニー インコーポレーテッド シクロオキシゲナーゼ―２媒介疾患の一日一回治療用組成物
CO4960662A1 (es) * 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
US20030114527A1 (en) * 2001-08-31 2003-06-19 Karnachi Anees Abdulquadar Pharmaceutical composition

Also Published As

Publication number Publication date
DE60129238T2 (de) 2008-03-06
EP1331972A2 (en) 2003-08-06
SK2902003A3 (en) 2003-10-07
AU2002213900C1 (en) 2006-07-27
CY1107729T1 (el) 2013-04-18
MY126117A (en) 2006-09-29
RU2316324C2 (ru) 2008-02-10
CA2416771A1 (en) 2002-03-14
WO2002020090A2 (en) 2002-03-14
JP2004527458A (ja) 2004-09-09
AU2002213900B2 (en) 2006-02-16
PE20020351A1 (es) 2002-06-14
CN100490797C (zh) 2009-05-27
PL359721A1 (en) 2004-09-06
NZ524785A (en) 2005-10-28
JP2011144194A (ja) 2011-07-28
MXPA03002105A (es) 2003-06-19
DK1331972T3 (da) 2007-11-05
WO2002020090A9 (en) 2003-10-30
ES2290181T3 (es) 2008-02-16
AR030630A1 (es) 2003-08-27
HUP0301128A3 (en) 2005-04-28
AU1390002A (en) 2002-03-22
EP1331972B1 (en) 2007-07-04
US20020061932A1 (en) 2002-05-23
CA2416771C (en) 2010-11-02
PT1331972E (pt) 2007-10-16
WO2002020090A3 (en) 2003-05-30
BR0113809A (pt) 2003-07-29
DE60129238D1 (de) 2007-08-16
CN1455691A (zh) 2003-11-12
CZ2003673A3 (cs) 2003-06-18
ATE366128T1 (de) 2007-07-15
HUP0301128A2 (hu) 2003-10-28
US20040186179A1 (en) 2004-09-23
IL154238A (en) 2008-11-26
IL154238A0 (en) 2003-09-17
SI1331972T1 (sl) 2007-12-31
NO20031095D0 (no) 2003-03-10
KR20030036730A (ko) 2003-05-09

Similar Documents

Publication Publication Date Title
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
ITMI20010748A0 (it) Composizioni farmaceutiche
DK1524266T3 (da) Farmaceutisk sammensætning
NO20025450L (no) Ny farmasöytisk sammensetning
ATE303787T1 (de) Schergelzusammensetzungen
ITTO20010008A0 (it) Formulazione farmaceutica
PT1242087E (pt) Composicoes farmaceuticas
FI20011478A (fi) Farmaseuttinen koostumus
NO20033556L (no) Farmasöytiske formuleringer
NO20015175D0 (no) Farmasöytisk sammensetning
AR028197A1 (es) Composiciones antitranspirantes
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
EE05020B1 (et) Glburiidi ravimkoostis
EE200300589A (et) Ravimkoostised
NO20026123L (no) Farmasöytiske sammensetninger
ATE369830T1 (de) Schweisshemmende zusammensetzungen
ATE314049T1 (de) Schweisshemmende zusammensetzungen
PT1239832E (pt) Composicoes farmaceuticas
FI20022128A (fi) Farmaseuttinen koostumus
NO20031095L (no) Farmasoytiske sammensetninger
DE60116858D1 (de) Zusammensetzung
FI4488U1 (fi) Farmaseuttinen koostumus
EE200200689A (et) Ravimkoostised
MXPA03001857A (es) Composicones medicinales.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application